Bleomycin	NN
and	CC
IL-1beta-mediated	JJ
pulmonary	JJ
fibrosis	NN
is	VBZ
IL-17A	NN
dependent	JJ
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
destructive	JJ
inflammatory	JJ
disease	NN
with	IN
limited	JJ
therapeutic	JJ
options	NNS
.	.

To	TO
better	RBR
understand	VB
the	DT
inflammatory	JJ
responses	NNS
that	WDT
precede	VBP
and	CC
concur	VBP
with	IN
collagen	NN
deposition	NN
,	,
we	PRP
used	VBD
three	CD
models	NNS
of	IN
pulmonary	JJ
fibrosis	NN
and	CC
identify	VB
a	DT
critical	JJ
mechanistic	JJ
role	NN
for	IN
IL-17A	NN
.	.

After	IN
exposure	NN
to	TO
bleomycin	NN
(	(
BLM	NN
)	)
,	,
but	CC
not	RB
Schistosoma	NN
mansoni	NNS
eggs	NNS
,	,
IL-17A	NN
produced	VBN
by	IN
CD4	NN
(	(
+	CC
)	)
and	CC
gammadelta	NN
(	(
+	CC
)	)
T	NN
cells	NNS
induced	VBD
significant	JJ
neutrophilia	NN
and	CC
pulmonary	JJ
fibrosis	NN
.	.

Studies	NNS
conducted	VBN
with	IN
C57BL/6	NN
il17a	NN
(	(
-	:
/	:
-	:
)	)
mice	NNS
confirmed	VBD
an	DT
essential	JJ
role	NN
for	IN
IL-17A	NN
.	.

Mechanistically	RB
,	,
using	VBG
ifngamma	NN
(	(
-	:
/	:
-	:
)	)
,	,
il10	NN
(	(
-	:
/	:
-	:
)	)
,	,
il10	NN
(	(
-	:
/	:
-	:
)	)
il12p40	NN
(	(
-	:
/	:
-	:
)	)
,	,
and	CC
il10	NN
(	(
-	:
/	:
-	:
)	)
il17a	NN
(	(
-	:
/	:
-	:
)	)
mice	NNS
and	CC
TGF-beta	NN
blockade	NN
,	,
we	PRP
demonstrate	VBP
that	IN
IL-17A-driven	JJ
fibrosis	NN
is	VBZ
suppressed	VBN
by	IN
IL-10	NN
and	CC
facilitated	VBN
by	IN
IFN-gamma	NN
and	CC
IL-12	NN
/	:
23p40	NN
.	.

BLM-induced	JJ
IL-17A	NN
production	NN
was	VBD
also	RB
TGF-beta	NN
dependent	JJ
,	,
and	CC
recombinant	JJ
IL-17A-mediated	JJ
fibrosis	NN
required	VBN
TGF-beta	NN
,	,
suggesting	VBG
cooperative	JJ
roles	NNS
for	IN
IL-17A	NN
and	CC
TGF-beta	NN
in	IN
the	DT
development	NN
of	IN
fibrosis	NN
.	.

Finally	RB
,	,
we	PRP
show	VBP
that	IN
fibrosis	NN
induced	VBN
by	IN
IL-1beta	NN
,	,
which	WDT
mimics	VBZ
BLM-induced	JJ
fibrosis	NN
,	,
is	VBZ
also	RB
highly	RB
dependent	JJ
on	IN
IL-17A	NN
.	.

IL-17A	NN
and	CC
IL-1beta	NN
were	VBD
also	RB
increased	VBN
in	IN
the	DT
bronchoalveolar	JJ
lavage	NN
fluid	NN
of	IN
patients	NNS
with	IN
IPF	NN
.	.

Together	RB
,	,
these	DT
studies	NNS
identify	VBP
a	DT
critical	JJ
role	NN
for	IN
IL-17A	NN
in	IN
fibrosis	NN
,	,
illustrating	VBG
the	DT
potential	JJ
utility	NN
of	IN
targeting	VBG
IL-17A	NN
in	IN
the	DT
treatment	NN
of	IN
drug	NN
and	CC
inflammation-induced	JJ
fibrosis	NN
.	.

